Viewing Study NCT00086632


Ignite Creation Date: 2025-12-24 @ 10:00 PM
Ignite Modification Date: 2026-02-21 @ 10:11 PM
Study NCT ID: NCT00086632
Status: TERMINATED
Last Update Posted: 2007-12-18
First Post: 2004-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment
Sponsor: Unither Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module